This content is 9 years old. Content may be out of date.

Newsletter Aug 2014

19 Feb 2015
WWARN Published Date
  • Image removed.An international collaboration supported by the WWARN team in Asia confirms that resistance to frontline antimalarial drug, artemisinin, is firmly established in many parts of Southeast Asia. The Tracking Resistance to Artemisinin Collaboration study reveals a potential short term solution to the growing problem.
  • Latest publication from WWARN Molecular Group investigates the association between genetic variation in the DNA of Plasmodium falciparum malaria and the efficacy of the two widely used antimalarial treatments, artesunate-amodiaquine (ASAQ) and artemether-lumefantrine (AL).
  • The new WWARN Pharmacology Publication Database collates all published data on antimalarial drug concentration since 1934.
  • The WWARN Clinical Group offers a timely and helpful service to clean, standardise and analyse your data.